Close

Merck (MRK) shares down 2% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. RDDT
4. GS
5. JPM
6. MSFT
7. SCHW
8. TCS:IN
9. UNH
10. ALAB


Go back to Merck (MRK) shares down 2% following Eli Lilly & Co. (LLY) failure of solanezumab data for Alzheimer's